Hyperthermic intraperitoneal chemotherapy in ovarian cancer: Qui Bono?

Ann Transl Med · 2020 · PMC7812203 · PMID 33490220

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Interestingly the neoadjuvant group showed a trend of improved survival in favour of HIPEC group after 30 m of OS and 20 m of RFS which necessitates further long term observation.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.